Imbria Pharmaceuticals website screenshot

Imbria Pharmaceuticals

Imbria Pharmaceuticals is a private, clinical-stage biopharmaceutical company based in the Boston area that is developing novel cardiovascular therapies targeting cardiac energy metabolism. Its lead candidate, ninerafaxstat, is a first-in-class partial fatty acid oxidation (pFOX) inhibitor designed to shift myocardial substrate utilization toward glucose oxidation, generating more ATP per unit of oxygen consumed and improving cardiac metabolic efficiency without affecting heart rate, rhythm, ejection fraction or blood pressure. Ninerafaxstat is in the global FORTITUDE-HCM Phase 2b trial (NCT07023614) for symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM), which has no approved treatments, and holds FDA Orphan Drug Designation for that indication; a Phase 2b in cardiometabolic HFpEF is planned. The company is backed by RA Capital, SV Health Investors, Deep Track Capital, Catalio Capital Management, AN Ventures and Cytokinetics. Imbria is a therapeutics developer, not a software vendor, and publishes no public API, developer portal, SDK or machine-readable API contract.

Imbria Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotechnology, Life Sciences, and Cardiovascular.

Imbria Pharmaceuticals’ developer surface includes engineering blog, support, and 13 more developer resources.

12.5/100 emerging ▬ flat Agent 0/100 human only Front door AI 1/6 silent Heartbeat 96/100 alive saas Full breakdown ↓
scored 2026-11-13 · rubric v0.28.0 · Show this score on your site →
0 APIs
CompanyPharmaceuticalsBiotechnologyLife SciencesCardiovascularClinical TrialsDrug DevelopmentHealthcareTherapeutics

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-11-13 · rubric v0.28.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site. Kin Score badge preview for Imbria Pharmaceuticals It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/imbria-pharmaceuticals/"><img src="https://apis.io/badge/imbria-pharmaceuticals/card.svg" alt="Imbria Pharmaceuticals on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
  • Machine-Readable Contract +18 pts — api_specs includes an OpenAPI document Ask about this →
  • MCP Server +12 pts — deployment.mode + probe verdict on the mcp/ manifest, not the pointer; an unprobed slug falls back to authorship Ask about this →
  • Agentic Access Contract +10 pts — agentic_access artifact present (x-agentic-access), graded by author Ask about this →
  • Machine-Readable Auth +10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey) Ask about this →
  • Idempotency +9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented) Ask about this →
  • Stable Error Semantics +8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes Ask about this →
13 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
Each check links to what satisfies it. Publish the artifact, or tell us where it already lives, and the score moves on the next scoring run.
Not sure how this applies to your stack? Ask about any one item. Kin Lane reads every question, looks at your profile and your situation, and replies with what a fix would take — scoped to that one area, priced up front, yours whether you ship it or not. Ask a question →
Ask about:
Imbria Pharmaceuticals · a person reads this and replies by email.
or email info@apis.io
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from the provider profile at artifacts.apis.io/imbria-pharmaceuticals/apis.yml: open an issue on github.com/api-evangelist/imbria-pharmaceuticals to ask a question or point us at an artifact you publish. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Terms of Service 1

What its API terms permit and prohibit, quoted from its own page.

Imbria Pharmaceuticals

10 quoted statements, read from Imbria Pharmaceuticals's own page on 2026-11-09.

TERMS

Privacy & Data 1

Its role, the data it processes, retention and transfers, quoted from its own privacy page.

Imbria Pharmaceuticals

16 quoted statements, read from Imbria Pharmaceuticals's own page on 2026-11-09.

PRIVACY

Eligibility 1

Who may sign up and where, quoted from its own terms.

Imbria Pharmaceuticals

4 quoted statements, read from Imbria Pharmaceuticals's own page on 2026-11-09.

ELIGIBILITY

AI Preferences 1

Its stance on AI training, inference and agents, quoted from its own pages.

Imbria Pharmaceuticals

1 quoted statement, read from Imbria Pharmaceuticals's own page on 2026-11-09.

AI PREFS

Data License 1

How its data and outputs may be reused, quoted from its own terms.

Imbria Pharmaceuticals

2 quoted statements, read from Imbria Pharmaceuticals's own page on 2026-11-09.

LICENSE

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Imbria Pharmaceuticals Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Documentation 1

Reference material describing how the API behaves

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 4

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 2

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: imbria-pharmaceuticals
name: Imbria Pharmaceuticals
description: Imbria Pharmaceuticals is a private, clinical-stage biopharmaceutical company based in the Boston area that is
  developing novel cardiovascular therapies targeting cardiac energy metabolism. Its lead candidate, ninerafaxstat, is a first-in-class
  partial fatty acid oxidation (pFOX) inhibitor designed to shift myocardial substrate utilization toward glucose oxidation,
  generating more ATP per unit of oxygen consumed and improving cardiac metabolic efficiency without affecting heart rate,
  rhythm, ejection fraction or blood pressure. Ninerafaxstat is in the global FORTITUDE-HCM Phase 2b trial (NCT07023614) for
  symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM), which has no approved treatments, and holds FDA Orphan Drug
  Designation for that indication; a Phase 2b in cardiometabolic HFpEF is planned. The company is backed by RA Capital, SV
  Health Investors, Deep Track Capital, Catalio Capital Management, AN Ventures and Cytokinetics. Imbria is a therapeutics
  developer, not a software vendor, and publishes no public API, developer portal, SDK or machine-readable API contract.
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  probe_state: none
  source:
  - security
  generated: '2026-11-13'
  method: derived
image: https://imbria.com/wp-content/uploads/2025/09/imbria_logo-1.svg
url: https://raw.githubusercontent.com/api-evangelist/imbria-pharmaceuticals/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Pharmaceuticals
- Biotechnology
- Life Sciences
- Cardiovascular
- Clinical Trials
- Drug Development
- Healthcare
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/imbria-pharmaceuticals-domain-security.yml
- type: Website
  url: https://imbria.com/
- type: About
  url: https://imbria.com/our-story/
- type: Blog
  url: https://imbria.com/investors-media/press-releases/
- type: BlogRSS
  url: https://imbria.com/feed/
- type: Support
  url: https://imbria.com/contact/
- type: TermsOfService
  url: https://imbria.com/terms-of-use/
- type: PrivacyPolicy
  url: https://imbria.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/imbria/
- type: LLMsTxt
  url: llms/imbria-pharmaceuticals-llms.txt
- type: UsageTerms
  url: terms/imbria-pharmaceuticals-terms-of-service.yml
- type: DataProcessing
  url: privacy/imbria-pharmaceuticals-privacy-policy.yml
- type: Eligibility
  url: eligibility/imbria-pharmaceuticals-eligibility.yml
- type: AIPreferences
  url: ai-preferences/imbria-pharmaceuticals-ai-preferences.yml
- type: DataLicense
  url: data-license/imbria-pharmaceuticals-data-license.yml
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Imbria Pharmaceuticals is a private clinical-stage biopharma developing ninerafaxstat for cardiovascular disease;
    imbria.com is a WordPress marketing site whose only machine-readable surface is the default WordPress core REST API at
    /wp-json/, and every developer-program path probed (/developers, /docs, /api, /openapi.json, /graphql, /llms.txt, /apis.json
    and eight /.well-known/ documents) returned the site's standard 404.
  evidence:
  - url: https://imbria.com/developers
    status: 404
  - url: https://imbria.com/openapi.json
    status: 404
  - url: https://imbria.com/.well-known/api-catalog
    status: 404
  - url: https://imbria.com/.well-known/agent-card.json
    status: 404
  - url: https://imbria.com/wp-json
    status: 200
  - url: https://github.com/imbria
    status: 404
  checked: '2026-08-22'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/imbria-pharmaceuticals"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/imbria-pharmaceuticals/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/imbria-pharmaceuticals/evidence"

Calls without X-API-Key need no key. Calls with it need a paid plan — get a key.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.